Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies

In the last decade there has been tremendous effort in offering better therapeutic management strategies to patients with hematologic malignancies. These efforts have ranged from biological to clinical approaches and resulted in the rapid development of new approaches. The main “problem” that comes...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Constantinescu, Catalin, Pasca, Sergiu, Zimta, Alina-Andreea, Tat, Tiberiu, Rus, Ioana, Teodorescu, Patric, Iluta, Sabina, Tanase, Alina, Colita, Anca, Sigurjonsson, Olafur, Einsele, Hermann, Tomuleasa, Ciprian
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Perspective
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565707/
https://ncbi.nlm.nih.gov/pubmed/32911829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092903
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky